News
PSYGF
0.139
NaN%
--
Psyence Partner GoldCoast Raises $8.6 Million, Clearing Key Merger Hurdle
TipRanks · 03/24 23:39
Psyence Advances GoldCoast Reverse Takeover as Partner Raises $5.8 Million
TipRanks · 03/20 14:37
Psyence Extends GoldCoast Amalgamation Timeline and Lowers Cash Condition
TipRanks · 02/24 16:40
Psyence RTO Target GoldCoast Wins Major Offshore Gold Reconnaissance Licences in Ghana
TipRanks · 01/27 16:34
Psyence Group says GoldCoast Resource granted offshore reconnaissance license
TipRanks · 01/27 14:55
Weekly Report: what happened at PSYGF last week (0908-0912)?
Weekly Report · 09/15/2025 11:10
Weekly Report: what happened at PSYGF last week (0901-0905)?
Weekly Report · 09/08/2025 11:12
Weekly Report: what happened at PSYGF last week (0825-0829)?
Weekly Report · 09/01/2025 11:07
Weekly Report: what happened at PSYGF last week (0818-0822)?
Weekly Report · 08/25/2025 11:17
Weekly Report: what happened at PSYGF last week (0811-0815)?
Weekly Report · 08/18/2025 11:10
Weekly Report: what happened at PSYGF last week (0804-0808)?
Weekly Report · 08/11/2025 11:16
Weekly Report: what happened at PSYGF last week (0728-0801)?
Weekly Report · 08/04/2025 11:20
Weekly Report: what happened at PSYGF last week (0721-0725)?
Weekly Report · 07/28/2025 11:20
Weekly Report: what happened at PSYGD last week (0714-0718)?
Weekly Report · 07/21/2025 11:10
Weekly Report: what happened at PSYGD last week (0707-0711)?
Weekly Report · 07/14/2025 11:19
Weekly Report: what happened at PSYGD last week (0630-0704)?
Weekly Report · 07/07/2025 11:11
Weekly Report: what happened at PSYGD last week (0623-0627)?
Weekly Report · 06/30/2025 11:17
PSYENCE GROUP INC. Announces Update on Previously Announced Non-Brokered Private Placement of Common Shares
Barchart · 06/25/2025 16:00
Weekly Report: what happened at PSYGD last week (0616-0620)?
Weekly Report · 06/23/2025 11:10
Psyence Group announces offering of up to C$600,000 non-brokered private placement of common shares
Seeking Alpha · 06/18/2025 21:42
More
Webull provides a variety of real-time PSYGF stock news. You can receive the latest news about Psyence Group through multiple platforms. This information may help you make smarter investment decisions.
About PSYGF
Psyence Group Inc. is a Canada-based life science biotechnology company with a focus on natural psychedelics. The Company is focused on the research, cultivation and production of psychedelics and nature-based compounds to treat psychological trauma in the context of palliative care and in support of mental wellness. It cultivates natural psilocybin mushrooms (Psilocybe Cubensis) at its federally licensed ISO22000 facility in Southern Africa. The Company’s divisions include Psyence Production, Psyence Therapeutics and Psyence Function. Psyence Therapeutics develops natural psilocybin products, medicinal formulations and treatment protocols to treat mental health disorders in a clinical environment. Psyence Production operates federally licensed ISO22000-certified psilocybin cultivation and production facilities in the world. Psyence Function is focused on the development, distribution and sale of over-the-counter functional mushroom nutraceutical products.